Clinical use of hematopoietic growth factors in the myelodysplastic syndromes
Ganser, A.; Hoelzer, D.
Seminars in Hematology 33(3): 186-195
1996
ISSN/ISBN: 0037-1963 PMID: 8819229 Document Number: 461920
Document emailed within 1 workday
Related Documents
Thomas, X.; Campos, L.; Bonnier, S.; Troncy, J.; Guyotat, D.; Fière, D. 1990: Response of hematopoietic precursor cells to hematopoietic growth factors in the myelodysplastic syndromes Nouvelle Revue Francaise d'Hematologie 32(5): 345-347Russell, N.H.; Reilly, I.A. 1989: Role of autocrine growth factors in the leukemic transformation of the myelodysplastic syndromes Leukemia 3(1): 83-84
García Marco, J.; Miguel Sosa, A.; García Conde, J.; Miguel García, A.; Arbona, C.; Escrig, V.; Benet, I.; Navarro, I.; Ruiz, A.; Carbonell, F. 1994: Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes Sangre 39(4): 241-244
Motoyoshi, K. 1990: Advances in hematopoietic growth factor research and bone marrow transplantation--hematopoietic stem cells and their growth factors Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 1941-1948
Polli, E.E.; Foa, P. 1991: Hematopoietic tissue growth factors: clinical factors Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 6(1 Part 1): 69-81
Löwenberg, B.; Dale, D.C.; Sheridan, W.P. 1994: Clinical use of hematopoietic growth factors Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion Suppl: 33-40
Gianni, A.M.; Bregni, M.; Siena, S.; Tarella, C.; DiNicola, M.; Bonadonna, G. 1991: Clinical use of hematopoietic growth factors Haematologica 76(Suppl 3): 3-10
Karthaus, M.; Ganser, A. 1996: Current status of the clinical application of hematopoietic growth factors in oncology Therapeutische Umschau. Revue Therapeutique 53(11): 863-873
Young, N.S. 1990: Hematopoietic growth factors: a summary of their biology in tissue culture, animals, and clinical trials Progress in Clinical and Biological Research 337: 539-549
Karthaus, M.; Ganser, A. 1997: Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology Zentralblatt für Gynakologie 119(12): 585-596
Schuening, F.G.; Nemunaitis, J.; Appelbaum, F.R.; Storb, R. 1994: Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials Bone Marrow Transplantation 14(Suppl 4): S74-S77
de Witte, T.; Brand, R.; van Biezen, A.; Delforge, M.; Biersack, H.; Or, R.; Meloni, G.; Bandini, B.; Sierra, J.; Kroger, N.; Gratwohl, A.; Niederwieser, D. 2006: The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes Haematologica 91(6): 750-756
Zamora-Pérez, E.; López-Karpovitch, X. 2015: Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin a (CSA) Gaceta Medica de Mexico 151(3): 345-353
Bernasconi, C.; Lazzarino, M.; Morra, E.; Alessandrino, E.P.; Brusamolino, E.; Bernasconi, P.; Inverardi, D. 1989: Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects Haematologica 74(5 Suppl): 110-127
Bernasconi, C.; Lazzarino, M.; Morra, E.; Alessandrino, E.P.; Brusamolino, E.; Bernasconi, P.; Inverardi, D. 1989: Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects Haematologica 74(5): 110-127
Giralt, M.; Rubio-Félix, D.; Sala, F.; Perdiguer, L.; Raichs, A. 1985: Clinical semiology, development and therapy of myelodysplastic syndromes Sangre 30(4-C): 705-712
Nisse, C.; Lorthois, C.; Dorp, V.; Eloy, E.; Haguenoer, J.M.; Fenaux, P. 1995: Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study Leukemia 9(4): 693-699
Pruneri, G.; Fracchiolla, N.; Cortelezzi, A.; Ponzoni, M.; Maisonneuve, P.; Lambertenghi-Deliliers, G. 2003: The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes Haematologica 88(1): 109-110
Greenberg, P.L. 1996: Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes Seminars in Hematology 33(2): 163-175
Liu, H.; He, G.-s.; Wu, D.-p.; Sun, A.-n.; Shao, Z.-h.; Qian, S.-x.; Xiao, Z.-j.; Ma, J.; Wang, S.-y.; Xu, X.-p.; Liu, T.; Jin, J.; Chen, Z.-c.; Fang, M.-y.; Chen, B.-a.; Xu, L.-p.; Shen, Z.-x.; Ruan, C.-g. 2012: Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study Zhonghua Yi Xue Za Zhi 92(10): 689-691